<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-13T16:49:58+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>JP摩根现场：今年的交易，中国企业比以往来得更猛一些……</title>
    <updated>2021-01-13T14:22:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/yGTjFe9UEiAhzV7bxyLk3Q</id>
    <link href="https://mp.weixin.qq.com/s/yGTjFe9UEiAhzV7bxyLk3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨中国肿瘤医药营销趋势论坛—市场及销售分论坛</title>
    <updated>2021-01-13T14:22:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/MJumnqImhpR1IotQcRraFw</id>
    <link href="https://mp.weixin.qq.com/s/MJumnqImhpR1IotQcRraFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物提交信迪利单抗+贝伐珠单抗一线治疗肝癌上市申请</title>
    <updated>2021-01-13T14:22:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/G7PXnNDp8wuBGHJs0nzWkA</id>
    <link href="https://mp.weixin.qq.com/s/G7PXnNDp8wuBGHJs0nzWkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罗氏“T+A”方案显著改善肝癌患者总生存期，中国亚群OS突破24个月</title>
    <updated>2021-01-13T14:22:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/TEJadrL536YtdiDLS0NPpQ</id>
    <link href="https://mp.weixin.qq.com/s/TEJadrL536YtdiDLS0NPpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个CAR-T疗法！复星凯特Yescarta即将获批上市</title>
    <updated>2021-01-12T13:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/SfmLjidgMynlgtUbe0Lsbw</id>
    <link href="https://mp.weixin.qq.com/s/SfmLjidgMynlgtUbe0Lsbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨中国肿瘤医药营销趋势论坛—准入及支付分论坛</title>
    <updated>2021-01-12T13:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/XuIS4-yK7--uVRF9OsucjA</id>
    <link href="https://mp.weixin.qq.com/s/XuIS4-yK7--uVRF9OsucjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE拟突破性疗法认定：安进KRAS抑制剂AMG 510治疗NSCLC</title>
    <updated>2021-01-12T13:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/LfPe0I6uNci5cONrCMrXcA</id>
    <link href="https://mp.weixin.qq.com/s/LfPe0I6uNci5cONrCMrXcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来阿尔茨海默病β淀粉样蛋白抗体疗法达到II期临床主要终点</title>
    <updated>2021-01-12T13:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/3jbqnX_Ym8UQ-a7CBcBw_g</id>
    <link href="https://mp.weixin.qq.com/s/3jbqnX_Ym8UQ-a7CBcBw_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物提交信迪利单抗二线治疗鳞状NSCLC上市申请</title>
    <updated>2021-01-12T13:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/OwglasT25ZhRLjhMB-vRzg</id>
    <link href="https://mp.weixin.qq.com/s/OwglasT25ZhRLjhMB-vRzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批集采品种多索茶碱注射液、盐酸氨溴索注射液再添新玩家</title>
    <updated>2021-01-12T13:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/KK0aoiYjnv3DUH85SmFkEg</id>
    <link href="https://mp.weixin.qq.com/s/KK0aoiYjnv3DUH85SmFkEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第3家！齐鲁「注射用头孢曲松钠」通过一致性评价</title>
    <updated>2021-01-12T13:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/hEuO8PaCcA3UJUCTtY2A6g</id>
    <link href="https://mp.weixin.qq.com/s/hEuO8PaCcA3UJUCTtY2A6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BioMarin血友病基因疗法III期研究成功：年化出血率下降84%，FVIII年输注率降低99%</title>
    <updated>2021-01-11T18:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/KPpH6fZSakUUvflbvVgZtg</id>
    <link href="https://mp.weixin.qq.com/s/KPpH6fZSakUUvflbvVgZtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“4+7”扩围续标ing，后续过评产品机会来了！</title>
    <updated>2021-01-11T18:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/Grx4d80wK5S_xsbtIZpNMQ</id>
    <link href="https://mp.weixin.qq.com/s/Grx4d80wK5S_xsbtIZpNMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>湖北省首批29个注射剂品种带量采购拟中选结果公布</title>
    <updated>2021-01-11T18:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/R49SqF2idQ02OljvN-Q02g</id>
    <link href="https://mp.weixin.qq.com/s/R49SqF2idQ02OljvN-Q02g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亘喜生物第2款靶向CD19的CAR-T疗法获批临床</title>
    <updated>2021-01-11T18:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/Vq7aBuw4CcNluj5a_BfObg</id>
    <link href="https://mp.weixin.qq.com/s/Vq7aBuw4CcNluj5a_BfObg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方核心行业数据监测周报（1月2-8日）</title>
    <updated>2021-01-11T18:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/mY5HboIm91m1ySzSYKY33A</id>
    <link href="https://mp.weixin.qq.com/s/mY5HboIm91m1ySzSYKY33A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上交所终止天士力生物科创板IPO</title>
    <updated>2021-01-09T17:28:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/Jvk9VY-_gVtLSsfqTC-mEQ</id>
    <link href="https://mp.weixin.qq.com/s/Jvk9VY-_gVtLSsfqTC-mEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江湖你我——2020年国内CRO行业回顾</title>
    <updated>2021-01-09T17:28:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/YG53IKwOCoKP64kSvbikXA</id>
    <link href="https://mp.weixin.qq.com/s/YG53IKwOCoKP64kSvbikXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12月肺癌月报 | 重磅文献18篇，新开关键临床试验12项</title>
    <updated>2021-01-09T17:28:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/SFZ3uU8-QgLp9Adujua-fw</id>
    <link href="https://mp.weixin.qq.com/s/SFZ3uU8-QgLp9Adujua-fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Alnylam第4款RNAi疗法III期研究成功</title>
    <updated>2021-01-08T18:14:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/7c6HEwK1xK4jTni7ybRwlQ</id>
    <link href="https://mp.weixin.qq.com/s/7c6HEwK1xK4jTni7ybRwlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>